Qianyuan Pharmaceuticals (300254.SZ) subsidiary obtains the drug registration certificate for Perindopril Amlodipine Tablets (II).

China Securities News App News, Qianyuan Pharmaceutical (300254.SZ) announced that recently, its subsidiary Hangzhou Qianyuan Baoling Pharmaceutical Co., Ltd. has received the "Perindopril Amlodipine Tablets (II)" Drug Registration Certificate issued by the National Medical Products Administration. The drug belongs to Category 4 chemical generic drugs. According to the relevant policies of domestic generic drug evaluation, approval is considered equivalent to passing consistency evaluation.